ArticleMolecular pharmaceutics2016

Selective Intracellular Delivery of Recombinant Arginine Deiminase (ADI) Using pH-Sensitive Cell Penetrating Peptides To Overcome ADI Resistance in Hypoxic Breast Cancer Cells.

Tzyy-Harn Yeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.